Truist reiterates buy on Amazon stock citing AWS partnership growth By Investing.com

Truist Securities reiterated a buy rating on Amazon with a $285 price target after AWS expanded its partnership with Anthropic, highlighting more than $100 billion of committed spend over 10 years and roughly $200 billion of Amazon capex in fiscal 2026. The firm said strong Claude demand and rising Trainium adoption could lift AWS revenue estimates by 25% year over year in the second half of 2026 and beyond. Amazon shares were cited at $248.28, near the 52-week high of $258.60, reflecting strong investor confidence.

Analysis

The key market takeaway is not the CEO headline; it is that Amazon is converting AI hype into a longer-dated, better-collateralized AWS demand curve. The Anthropic commitment effectively de-risks a meaningful slice of planned capex and should improve investor willingness to underwrite a higher terminal growth rate for AWS, which matters more to valuation than near-term earnings optics. The second-order winner is not just Amazon equity, but its captive stack: Trainium, custom networking, power procurement, and data center contractors all gain incremental budget certainty.

This also changes the competitive map. If AWS can lock in frontier-model workloads on proprietary silicon, it narrows the economic moat gap versus hyperscalers that are still more exposed to merchant GPU supply and third-party inference economics. The likely loser is any AI infrastructure vendor whose valuation assumes perpetual scarcity pricing for compute; committed workload migration reduces the bargaining power of GPU suppliers and forces the market to reassess the durability of peak-margin assumptions.

The main risk is timing mismatch: the stock is already discounting a strong 2026–27 AI monetization ramp, while the actual revenue inflection may remain back-end loaded and dependent on model adoption staying explosive. If model spend normalizes, or if capex intensity rises faster than AWS backlog converts to revenue, the market could punish free cash flow before it rewards growth. In that sense, the setup is bullish over 6–18 months, but vulnerable to any quarter where capex guide rises without a corresponding order-book surprise.

Contrarian read: the consensus may be underestimating how much of the upside is already embedded in the multiple. The real incremental catalyst is not further price-target hikes, but evidence that Trainium meaningfully displaces external accelerators at scale, which would expand AWS margins over time. If that proof point stalls, the current enthusiasm could revert to a 'great business, expensive stock' regime faster than bulls expect.

Key Decisions for Investors

• Long AMZN into the next AWS earnings cycle; target a 6–12 month hold with upside driven by AI backlog conversion and capex de-risking. Risk/reward is favorable if the market starts capitalizing 2026 AWS growth earlier than consensus.
• Buy AMZN Jan-2027 call spreads to express upside from AWS/AI monetization while limiting downside if capex stays heavy longer than expected. Best used on pullbacks toward the 50-day rather than strength chasing.
• Pair trade: long AMZN / short a basket of high-multiple GPU-exposure names that rely on scarcity pricing, for example SMCI on rallies. The trade benefits if hyperscaler self-supply and committed workloads compress infrastructure margins elsewhere.
• Avoid chasing NI as a pure beneficiary; treat power/infrastructure exposure as a slower-burn beneficiary with execution risk. Better entry is on any selloff if the market prices in multi-year data-center load growth rather than headline enthusiasm.
• Take profits on any existing AMZN long if the stock approaches the upper end of analyst target dispersion without a visible AWS backlog re-acceleration. The setup is strong, but multiple expansion can outrun fundamentals in the short term.